CD8A and melanoma: Nick Restifo and colleagues developed the Pmel-1 transgenic mouse model, in which more than 95% of all CD8+ T cells recognize an epitope from the murine gp100 melanoma-associated antigen, to study TCR gene transfer to mice with B16 melanoma 88.